Effect of body mass index on treatment response of biologic/targeted-synthetic DMARDs in patients with rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis. A systematic review
Chrysoula G. Gialouri, Μαρία Παππά, Gerasimos Evangelatos, Elena Nikiphorou, G. Fragoulis
Topics & Concepts
MedicinePsoriatic arthritisTocilizumabInternal medicineRheumatoid arthritisAbataceptRandomized controlled trialTofacitinibOverweightBody mass indexTNF inhibitorAdalimumabCochrane LibraryOncologyRituximabLymphomaSpondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research